Quadrant Capital Group LLC Enanta Pharmaceuticals Inc Transaction History

Quadrant Capital Group LLC

  • $1.42 Billion
  • Q3 2024

A detailed history of Quadrant Capital Group LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Quadrant Capital Group LLC holds 35 shares of ENTA stock, worth $317. This represents 0.0% of its overall portfolio holdings.

Number of Shares
35
Previous 35 -0.0%
Holding current value
$317
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024
SELL
$11.43 - $17.02 $1,417 - $2,110
-124 Reduced 77.99%
35 $0
Q1 2024

May 15, 2024
BUY
$10.08 - $17.46 $1,249 - $2,165
124 Added 354.29%
159 $2,000
Q4 2023

Feb 08, 2024
SELL
$8.18 - $10.78 $9,169 - $12,084
-1,121 Reduced 96.97%
35 $0
Q3 2023

Nov 14, 2023
BUY
$11.09 - $22.13 $11,910 - $23,767
1,074 Added 1309.76%
1,156 $12,000
Q2 2023

Aug 09, 2023
SELL
$20.68 - $39.85 $5,935 - $11,436
-287 Reduced 77.78%
82 $1,000
Q1 2023

May 11, 2023
SELL
$38.82 - $54.59 $1,397 - $1,965
-36 Reduced 8.89%
369 $14,000
Q4 2022

Feb 10, 2023
BUY
$40.77 - $53.73 $5,340 - $7,038
131 Added 47.81%
405 $18,000
Q3 2022

Nov 10, 2022
BUY
$48.29 - $71.27 $4,056 - $5,986
84 Added 44.21%
274 $14,000
Q2 2022

Aug 09, 2022
BUY
$38.13 - $76.93 $457 - $923
12 Added 6.74%
190 $9,000
Q1 2022

May 06, 2022
BUY
$56.06 - $74.11 $784 - $1,037
14 Added 8.54%
178 $13,000
Q4 2021

Feb 01, 2022
SELL
$60.19 - $97.37 $1,564 - $2,531
-26 Reduced 13.68%
164 $12,000
Q3 2021

Nov 12, 2021
BUY
$41.02 - $58.65 $656 - $938
16 Added 9.2%
190 $11,000
Q2 2021

Aug 09, 2021
SELL
$43.76 - $53.11 $918 - $1,115
-21 Reduced 10.77%
174 $8,000
Q1 2021

May 12, 2021
BUY
$41.69 - $54.95 $1,250 - $1,648
30 Added 18.18%
195 $10,000
Q4 2020

Feb 16, 2021
BUY
$41.16 - $47.47 $3,704 - $4,272
90 Added 120.0%
165 $7,000
Q3 2020

Nov 13, 2020
BUY
$43.36 - $53.53 $1,430 - $1,766
33 Added 78.57%
75 $3,000
Q2 2020

Aug 13, 2020
SELL
$46.37 - $57.58 $22,767 - $28,271
-491 Reduced 92.12%
42 $2,000
Q1 2020

May 15, 2020
BUY
$40.22 - $62.0 $19,748 - $30,442
491 Added 1169.05%
533 $28,000
Q1 2018

May 10, 2018
SELL
$57.91 - $92.15 $2,432 - $3,870
-42 Closed
0 $0
Q2 2017

Aug 15, 2017
BUY
N/A
42
42 $0

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $188M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Quadrant Capital Group LLC Portfolio

Follow Quadrant Capital Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quadrant Capital Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Quadrant Capital Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email